PR
Prelude Therapeutics Incorporated
PRLD · NASDAQ
$5.30 -0.19% (-$0.01)
1M +9.73%
Market Cap $416.0M
P/E Ratio -
Div. Yield -
ROE 75.35%
Bulios Fair Price
$3.64
31.3% downside
Trenutna cena
$5.3
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PRLD trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
33 /100
Expensive P/B 3.11x
P/S 18.55x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 29.45%
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak Net margin 269.75%
Op. margin 300.56%
FCF margin 148.30%
Quality
2 /100
Poor ROE 75.35%
ROA 31.94%
Asset turnover 0.12x
Debt
100 /100
Low Current ratio 4.07x
Debt/Equity 0.13x
Net debt/EBITDA N/A
Stability
77 /100
Stable EPS volatility 6.10%
Profitable years 0
Beta 0.96x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PRLD
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Krishna Vaddi
Employees
79
Headquarters
Wilmington
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report